{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:48:35Z","timestamp":1761709715592,"version":"3.41.2"},"reference-count":55,"publisher":"Portland Press Ltd.","issue":"4","license":[{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The complement factor I (CFI) gene polymorphisms have been reported to age-related macular degenerative (AMD) risk, nevertheless, above association is not consistent. We investigated a meta-analysis to evaluate the conclusions between CFI polymorphisms (rs10033900 and rs2285714) and AMD risk. An identification was covered with the PubMed and other databases through February 8, 2020. Odds ratios (OR) and 95% confidence intervals (CI) were used to assess the strength of associations. After a comprehensive search, 11 different articles (12 case\u2013control studies for total AMD and 11 case\u2013control studies about neovascular disease\/geographic atrophy in AMD) were retrieved. Individuals carrying C-allele or CC genotype of rs10033900 polymorphism may have a decreased risk to be AMD disease. For example, there has a significantly decreased relationship between rs10033900 polymorphism and AMD both in the whole group, Caucasian population and population-based source of control. Moreover, a similar trend in subgroup of genotype method group by MALDI-TOF MS was detected. To classify the type of AMD in further, decreased association was also observed in both neovascular disease and geographic atrophy AMD. No association was found about rs2285714 polymorphism. Our present groundbreaking study suggests that the CFI rs10033900 polymorphism is potentially associated with the risk of AMD development.<\/jats:p>","DOI":"10.1042\/bsr20200406","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T14:47:49Z","timestamp":1585234069000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Complement family member CFI polymorphisms and AMD susceptibility from a comprehensive analysis"],"prefix":"10.1042","volume":"40","author":[{"given":"Qianqian","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Affiliated Wuxi People\u2019s Hospital of Nanjing Medical University, Wuxi, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Affiliated Wuxi People\u2019s Hospital of Nanjing Medical University, Wuxi, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6757-930X","authenticated-orcid":false,"given":"Yong","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Affiliated Wuxi People\u2019s Hospital of Nanjing Medical University, Wuxi, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Affiliated Wuxi People\u2019s Hospital of Nanjing Medical University, Wuxi, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2020,4,9]]},"reference":[{"key":"2021111620065688500_B1","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1056\/NEJMra080153710.1056\/NEJMra0801537","article-title":"Age-related macular degeneration","volume":"358","author":"Jager","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"2021111620065688500_B2","doi-asserted-by":"publisher","first-page":"C18","DOI":"10.12968\/hmed.2016.77.2.C1810.12968\/hmed.2016.77.2.C18","article-title":"Age-related macular degeneration","volume":"77","author":"Ong","year":"2016","journal-title":"Brit. J. Hospital Med. (London, England: 2005)"},{"key":"2021111620065688500_B3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3892\/ijmm.2015.211610.3892\/ijmm.2015.2116","article-title":"Caffeic acid phenethyl ester reduces the secretion of vascular endothelial growth factor through the inhibition of the ROS, PI3K and HIF-1alpha signaling pathways in human retinal pigment epithelial cells under hypoxic conditions","volume":"35","author":"Paeng","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"2021111620065688500_B4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40662-016-0063-510.1186\/s40662-016-0063-5","article-title":"Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors","volume":"3","author":"Pennington","year":"2016","journal-title":"Eye Vision (London, England)"},{"key":"2021111620065688500_B5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archopht.124.4.52910.1001\/archopht.124.4.529","article-title":"Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE)","volume":"124","author":"Augood","year":"2006","journal-title":"Arch. Ophthalmol. (Chicago, Ill: 1960)"},{"key":"2021111620065688500_B6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2415-10-3110.1186\/1471-2415-10-31","article-title":"Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis","volume":"10","author":"Chakravarthy","year":"2010","journal-title":"BMC Ophthalmol."},{"key":"2021111620065688500_B7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.preteyeres.2009.10.00110.1016\/j.preteyeres.2009.10.001","article-title":"Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?","volume":"29","author":"Laude","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"2021111620065688500_B8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.110955710.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"2021111620065688500_B9","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1073\/pnas.091201910710.1073\/pnas.0912019107","article-title":"Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC)","volume":"107","author":"Neale","year":"2010","journal-title":"PNAS"},{"key":"2021111620065688500_B10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/ng.93810.1038\/ng.938","article-title":"Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population","volume":"43","author":"Arakawa","year":"2011","journal-title":"Nat. Genet."},{"key":"2021111620065688500_B11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev-genom-090413-02561010.1146\/annurev-genom-090413-025610","article-title":"Age-related macular degeneration: genetics and biology coming together","volume":"15","author":"Fritsche","year":"2014","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"2021111620065688500_B12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-3083.2006.01729.x","article-title":"Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H","volume":"63","author":"Reis","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"2021111620065688500_B13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9394(02)01624-010.1016\/S0002-9394(02)01624-0","article-title":"A role for local inflammation in the formation of drusen in the aging eye","volume":"134","author":"Anderson","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"2021111620065688500_B14","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1073\/pnas.050153610210.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"PNAS"},{"key":"2021111620065688500_B15","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1089\/gtmb.2018.011010.1089\/gtmb.2018.0110","article-title":"Association Between Complement Factor C2\/C3\/CFB\/CFH Polymorphisms and Age-Related Macular Degeneration: A Meta-Analysis","volume":"22","author":"Lu","year":"2018","journal-title":"Genetic Test. Mole Biomark."},{"key":"2021111620065688500_B16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40662-019-0161-210.1186\/s40662-019-0161-2","article-title":"Evaluation of the association of C5 with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"6","author":"Liu","year":"2019","journal-title":"Eye Vision (London, England)"},{"key":"2021111620065688500_B17","first-page":"861","article-title":"Complement factor B polymorphism (rs641153) and susceptibility to age-related macular degeneration: evidence from published studies","volume":"6","author":"Wang","year":"2013","journal-title":"Int. J. Ophthalmol."},{"key":"2021111620065688500_B18","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1111\/aos.1384910.1111\/aos.13849","article-title":"The association between complement factor H rs1061170 polymorphism and age-related macular degeneration: a comprehensive meta-analysis stratified by stage of disease and ethnicity","volume":"97","author":"Maugeri","year":"2019","journal-title":"Acta Ophthalmol. (Copenh)"},{"key":"2021111620065688500_B19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.gene.2015.02.03910.1016\/j.gene.2015.02.039","article-title":"Nonsynonymous single nucleotide polymorphisms in the complement component 3 gene are associated with risk of age-related macular degeneration: a meta-analysis","volume":"561","author":"Qian-Qian","year":"2015","journal-title":"Gene"},{"key":"2021111620065688500_B20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.imbio.2011.07.01910.1016\/j.imbio.2011.07.019","article-title":"Age-related macular degeneration and the complement system","volume":"217","author":"Khandhadia","year":"2012","journal-title":"Immunobiology"},{"key":"2021111620065688500_B21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molimm.2010.08.01610.1016\/j.molimm.2010.08.016","article-title":"Transcriptional control of genes for soluble complement cascade regulatory proteins","volume":"48","author":"Fraczek","year":"2010","journal-title":"Mol. Immunol."},{"key":"2021111620065688500_B22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ejhg.2008.14010.1038\/ejhg.2008.140","article-title":"Variation near complement factor I is associated with risk of advanced AMD","volume":"17","author":"Fagerness","year":"2009","journal-title":"European J. Human Genetics: EJHG"},{"key":"2021111620065688500_B23","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1167\/iovs.09-3928","article-title":"Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes","volume":"50","author":"Reynolds","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2021111620065688500_B24","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/ejhg.2009.24310.1038\/ejhg.2009.243","article-title":"Additional evidence to support the role of a common variant near the complement factor I gene in susceptibility to age-related macular degeneration","volume":"18","author":"Kondo","year":"2010","journal-title":"Eur. J. Human Genet.: EJHG"},{"key":"2021111620065688500_B25","first-page":"2412","article-title":"Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration","volume":"16","author":"Seddon","year":"2010","journal-title":"Mol. Vis."},{"key":"2021111620065688500_B26","doi-asserted-by":"publisher","first-page":"1005.e1","DOI":"10.1016\/j.ajo.2011.05.01610.1016\/j.ajo.2011.05.016","article-title":"Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study","volume":"152","author":"Peter","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"2021111620065688500_B27","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1167\/iovs.10-7070","article-title":"Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration","volume":"52","author":"Yu","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2021111620065688500_B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ejhg.2011.11810.1038\/ejhg.2011.118","article-title":"No evidence of association between complement factor I genetic variant rs10033900 and age-related macular degeneration","volume":"20","author":"Cipriani","year":"2012","journal-title":"Eur. J. Human Genet.: EJHG"},{"key":"2021111620065688500_B29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ophtha.2011.07.05610.1016\/j.ophtha.2011.07.056","article-title":"Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration","volume":"119","author":"Smailhodzic","year":"2012","journal-title":"Ophthalmology"},{"key":"2021111620065688500_B30","first-page":"350","article-title":"Association of single nucleotide polymorphism in complement factor I gene with age-related macular degeneration","volume":"49","author":"Wu","year":"2013","journal-title":"Chin. J. Ophthalmol."},{"key":"2021111620065688500_B31","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/ejhg.2014.3710.1038\/ejhg.2014.37","article-title":"Common variant rs10033900 near the complement factor I gene is associated with age-related macular degeneration risk in Han Chinese population","volume":"22","author":"Qian","year":"2014","journal-title":"Eur. J. Human Genet.: EJHG"},{"key":"2021111620065688500_B32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/00035824110.1159\/000358241","article-title":"Complement factor I polymorphism is not associated with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in a chinese population","volume":"232","author":"Yang","year":"2014","journal-title":"Ophthalmol. J. Int. D'ophtalmologie Int. J. Ophthalmol. Zeitschrift fur Augenheilkunde"},{"key":"2021111620065688500_B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000503327","article-title":"Complement Factor I Gene Polymorphism in a Turkish Age-Related Macular Degeneration Population","author":"Bezci Aygun","year":"2019","journal-title":"Ophthalmol. J. Int. D'ophtalmologie Int. J. Ophthalmology Zeitschrift fur Augenheilkunde"},{"key":"2021111620065688500_B34","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archopht.123.11.1484","article-title":"The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17","volume":"123","author":"Davis","year":"2005","journal-title":"Archiv. Ophthalmol. (Chicago, Ill: 1960)"},{"key":"2021111620065688500_B35","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.118610.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"2021111620065688500_B36","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J. Natl. Cancer Inst."},{"key":"2021111620065688500_B37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-210.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"2021111620065688500_B38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.imlet.2014.08.00910.1016\/j.imlet.2014.08.009","article-title":"The relevance of checking population allele frequencies and Hardy-Weinberg Equilibrium in genetic association studies: the case of SLC6A4 5-HTTLPR polymorphism in a Chinese Han Irritable Bowel Syndrome association study","volume":"162","author":"Napolioni","year":"2014","journal-title":"Immunol. Lett."},{"key":"2021111620065688500_B39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2188\/jea.15.23510.2188\/jea.15.235","article-title":"Systematic evaluation and comparison of statistical tests for publication bias","volume":"15","author":"Hayashino","year":"2005","journal-title":"J. Epidemiol."},{"key":"2021111620065688500_B40","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.18632\/aging.10150910.18632\/aging.101509","article-title":"Human methionine synthase A2756G polymorphism increases susceptibility to prostate cancer","volume":"10","author":"Shao","year":"2018","journal-title":"Aging"},{"key":"2021111620065688500_B41","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/eye.2015.4810.1038\/eye.2015.48","article-title":"Defining response to anti-VEGF therapies in neovascular AMD","volume":"29","author":"Amoaku","year":"2015","journal-title":"Eye"},{"key":"2021111620065688500_B42","first-page":"527","article-title":"Anti-VEGF Therapy for Neovascular AMD and Polypoidal Choroidal Vasculopathy","volume":"6","author":"Cheung","year":"2017","journal-title":"Asia-Pacific J. Ophthalmol. (Philadelphia, Pa)"},{"key":"2021111620065688500_B43","doi-asserted-by":"publisher","first-page":"e000398","DOI":"10.1136\/bmjophth-2019-00039810.1136\/bmjophth-2019-000398","article-title":"Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review","volume":"4","author":"Khanna","year":"2019","journal-title":"BMJ Open Ophthalmol."},{"key":"2021111620065688500_B44","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-710.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet (London, England)"},{"key":"2021111620065688500_B45","first-page":"Cd011230","article-title":"Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration","author":"Moja","year":"2014","journal-title":"Cochrane Database. Syst. Rev."},{"key":"2021111620065688500_B46","first-page":"Cd005139","article-title":"Anti-vascular endothelial growth factor for neovascular age-related macular degeneration","author":"Solomon","year":"2014","journal-title":"Cochrane Database. Syst. Rev."},{"key":"2021111620065688500_B47","first-page":"5397","article-title":"Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis","volume":"9","author":"Ba","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"2021111620065688500_B48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.molimm.2016.11.01610.1016\/j.molimm.2016.11.016","article-title":"The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment","volume":"84","author":"Geerlings","year":"2017","journal-title":"Mol. Immunol."},{"key":"2021111620065688500_B49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00281-017-0649-610.1007\/s00281-017-0649-6","article-title":"The eye as a complement dysregulation hotspot","volume":"40","author":"Clark","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"2021111620065688500_B50","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.ajpath.2016.03.02110.1016\/j.ajpath.2016.03.021","article-title":"The Complement Regulatory Protein CD46 Deficient Mouse Spontaneously Develops Dry-Type Age-Related Macular Degeneration-Like Phenotype","volume":"186","author":"Lyzogubov","year":"2016","journal-title":"Am. J. Pathol."},{"key":"2021111620065688500_B51","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.exer.2019.05.00610.1016\/j.exer.2019.05.006","article-title":"The role of complement membrane attack complex in dry and wet AMD - From hypothesis to clinical trials","volume":"184","author":"Kumar-Singh","year":"2019","journal-title":"Exp. Eye Res."},{"key":"2021111620065688500_B52","doi-asserted-by":"publisher","first-page":"7532507","DOI":"10.1155\/2018\/753250710.1155\/2018\/7532507","article-title":"Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine","volume":"2018","author":"Maugeri","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"2021111620065688500_B53","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.2147\/DDDT.S20635510.2147\/DDDT.S206355","article-title":"Complement system and age-related macular degeneration: drugs and challenges","volume":"13","author":"Wu","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"2021111620065688500_B54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bpj.2018.12.00710.1016\/j.bpj.2018.12.007","article-title":"Molecular Mechanisms of Macular Degeneration Associated with the Complement Factor H Y402H Mutation","volume":"116","author":"Harrison","year":"2019","journal-title":"Biophys. J."},{"key":"2021111620065688500_B55","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12886-018-0945-510.1186\/s12886-018-0945-5","article-title":"Association between genetic variation of complement C3 and the susceptibility to advanced age-related macular degeneration: a meta-analysis","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Ophthalmol."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20200406\/871536\/bsr-2020-0406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20200406\/871536\/bsr-2020-0406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T20:44:11Z","timestamp":1637095451000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/40\/4\/BSR20200406\/222471\/Complement-family-member-CFI-polymorphisms-and-AMD"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,30]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20200406","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"type":"print","value":"0144-8463"},{"type":"electronic","value":"1573-4935"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2020,4]]},"article-number":"BSR20200406"}}